SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-05-246696
Filing Date
2005-12-21
Accepted
2005-12-21 17:17:25
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ds3a.htm S-3/A 479559
2 OPINION OF O'MELVENY & MYERS, LLP dex51.htm EX-5.1 8383
3 LETTER REGARDING UNAUDITED FINANCIAL INFORMATION dex151.htm EX-15.1 3336
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2311
5 CONSENT OF GRANT THORNTON LLP dex232.htm EX-23.2 1954
6 GRAPHIC g20549imagecti.jpg GRAPHIC 8835
  Complete submission text file 0001193125-05-246696.txt   509249
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-130411 | Film No.: 051279318
SIC: 2834 Pharmaceutical Preparations